RT Journal Article
SR Electronic
T1 Metabolic disorders and the risk of head and neck cancer: a protocol for a systematic review and meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.14.21264986
DO 10.1101/2021.10.14.21264986
A1 Gormley, Alexander
A1 Richards, Charlotte
A1 Spiga, Francesca
A1 Gray, Emily
A1 Hooper, Joanna
A1 Main, Barry G
A1 Vincent, Emma E
A1 Richmond, Rebecca C
A1 Higgins, Julian PT
A1 Gormley, Mark
YR 2021
UL http://medrxiv.org/content/early/2021/10/16/2021.10.14.21264986.abstract
AB Introduction Head and neck cancer squamous cell carcinoma (HNSCC) is the 6th most common cancer internationally. Established risk factors include smoking, alcohol and presence of human papillomavirus (HPV). The incidence rate of new disease continues to rise, despite falls in alcohol consumption and a reduction in smoking, the rising rates are unlikely to be solely attributed to HPV status alone. Obesity and its associated conditions such as type 2 diabetes (T2D) are implicated in the risk and progression of a variety of cancers but there is paucity of evidence regarding its role in HNSCC.Methods and analysis A systematic review of cohort studies, reporting a risk of incident head and neck squamous cell carcinoma will be included. A systematic search strategy has been developed, multiple databases will be searched from January 1966, including Cochrane Library, OVID SP versions of Medline and EMBASE. The primary outcome will be incident HNSCC based on exposures of type 2 diabetes, obesity, dyslipidemia and hypertension as defined by the World Health Organisation (WHO). A combined risk effect across studies will be calculated using meta-analysis, although depending on the heterogeneity in study design, exposure and outcome reporting this may not be possible.Ethics and dissemination No ethical approval is required for this systematic review. The review will be published in a revelant peer-review journal and findings will be presented at scientific meetings in both poster and oral presentation form.Registration details This study has been registered with the international prospective register of systematic reviews (PROSPERO) with study registration number CRD42021250520. This protocol has been developed in accordance with the preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) guidance statement.Strengths and limitations of this studyThis systematic review will be the first to comprehensively review the literature and provide a meta-analysis of the effect of metabolic disorders and the risk of incident HNSCC.The publication of this protocol provides a clear representation of the methods used in this review for transparency and to prevent future duplication.This systematic review will be one of the first to pilot the The ROBINS-E tool (Risk Of Bias In Non-randomised Studies - of Exposures).Despite the metabolic disorders being described as separate entities, the authors recognise the potential for disease processes to be related.Among cohort studies there is significant variability in terms of length of follow-up for the outcome of interest, HNSCC.Competing Interest StatementThe authors have declared no competing interest.Funding StatementA.G. is a National Institute for Health Research (NIHR) academic clinical fellow. F.S. was supported by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme). E.E.V is supported by Diabetes UK (17/0005587). E.E.V is also supported by the World Cancer Research Fund (WCRF UK), as part of the World Cancer Research Fund International grant programme (IIG_2019_2009). R.C.R. is a de Pass VC research fellow at the University of Bristol. J.P.T.H supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, the NIHR Applied Research Collaboration West at University Hospitals Bristol and Weston NHS Foundation Trust and is a National Institute for Health Research (NIHR) Senior Investigator. M.G. is currently supported by a Wellcome Trust GW4-Clinical Academic Training PhD Fellowship. This research was funded in part, by the Wellcome Trust [Grant number 220530/Z/20/Z]. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. The views expressed in this publication are those of the author(s) and not necessarily those of Wellcome, NIHR, the NHS or Department of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is a protocol for a systematic review where no primary data will be collected, the search strategy is included in the supplementary data for where the data for this systematic review will be obtained from.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is a protocol for a systematic review where no primary data will be collected, the search strategy is included in the supplementary data for where the data for this systematic review will be obtained from.